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membrane proteins in cellular membranes. However, in addition to the FRET of sequence-specific interactions, these experi-
ments invariably record a contribution due to proximity FRET, which occurs when a donor and an acceptor approach each other
by chance within distances of ~100 A˚. This effect does not reflect specific interactions in the membrane and is frequently
unappreciated, despite the fact that its magnitude can be significant. Here we develop a computational description of proximity
FRET, simulating the cases of proximity FRET when fluorescent proteins are used to tag monomeric, dimeric, trimeric, and tetra-
meric membrane proteins, as well as membrane proteins existing in monomer-dimer equilibria. We also perform rigorous exper-
imental measurements of this effect, by identifying membrane receptors that do not associate in mammalian membranes. We
measure the FRET efficiencies between yellow fluorescent protein and mCherry-tagged versions of these receptors in
plasma-membrane-derived vesicles as a function of receptor concentration. Finally, we demonstrate that the experimental mea-
surements are well described by our predictions. The work presented here brings additional rigor to FRET-based studies of
membrane protein interactions, and should have broad utility in membrane biophysics research.INTRODUCTIONApproximately one-third of the open reading frames in the
human genome encode for membrane proteins in the form
of receptors, transporters, and channels, to name a few.
The function of many of these proteins is regulated by their
interactions with partners in the membrane. For instance,
some membrane proteins are active as dimers or higher-
order oligomers, but are inactive in the monomeric state
(1–3). In other cases, activity of a protein is controlled by
its heterointeraction with a structurally unrelated partner
(4,5). Although such interactions are critical for normal
biological function and are implicated in many diseases,
our knowledge of membrane protein interactions is often
qualitative and rudimentary, and lags far behind the knowl-
edge of soluble protein interactions.
Many of the label-free techniques that are commonly
used to study soluble protein interactions cannot be
extended to membrane proteins in their native environment.
Instead, fluorescence methods, particularly approaches that
rely on Fo¨rster resonance energy transfer (FRET), are often
used (6-10). A major advantage of the FRET-based assess-
ment of molecular interactions in the membrane is that
experiments can be performed in cells or in a cell-derived
system, without the need for membrane protein extraction
and purification.
FRET involves the nonradiative transfer of energy from
an optically excited donor to an appropriate acceptor mole-Submitted November 20, 2013, and accepted for publication January 27,
2014.
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0006-3495/14/03/1309/9 $2.00cule (11). In FRET experiments, the membrane proteins of
interest are tagged with genetically encoded donor and
acceptor fluorescent proteins such as cyan fluorescent
protein, green fluorescent protein, yellow fluorescent pro-
tein (YFP), and mCherry (12–14). The steady-state FRET
efficiency in this case can be easily measured in a standard
fluorescence microscope. However, quantitative assessment
of the strength of interactions between the tagged membrane
proteins remains a challenge, partially because of the
unknown proximity-FRET contribution to the steady-state
FRET efficiency. Proximity FRET occurs when a donor
and an acceptor approach each other by chance within
distances of about two Fo¨rster radii and does not reflect
specific interactions between the tagged membrane proteins
(15). The magnitude of this effect is significant, because the
fluorophores are confined in two dimensions. Without a
correction for proximity FRET, the results of a FRET-based
measurement of membrane protein interactions can be
incorrect and misleading. Thus, it is critical that the effect
is understood and reliably predicted even in cases when it
is not directly measurable.
Wolber and Hudson developed a model for FRET in two
dimensions that accounts for random encounters of donors
and acceptors, assuming that the size of donors and accep-
tors is negligible (15). This theoretical model has been
shown to explain FRET data in lipid bilayers when the
donor and the acceptor are small organic molecules
(16–18). However, the model is not applicable to large
b-barrel fluorescent proteins used in cellular studies because
of their rather large finite size (~3–4 nm), which limits the
distance of closest approach between donors and acceptors.
A model that is useful in this case was developed by Snyderhttp://dx.doi.org/10.1016/j.bpj.2014.01.039
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imity FRET for monomeric fluorophores with finite size that
are confined to a plane in two dimensions (19). However, the
case of proximity FRET for fluorophores attached to mem-
brane proteins that form constitutive oligomers or exist in a
monomer-dimer equilibrium has never been considered in
the literature. Such a proximity-FRET contribution can be
expected to occur, but its exact magnitude is unknown.
Along with the challenges in developing reliable pre-
dictions of proximity FRET, there have also been challenges
in the experimental assessment of the effect. There have
been no rigorous measurements of proximity FRET as a
function of concentration with fluorescent protein-tagged,
noninteracting membrane proteins. In fact, as the protein
interaction networks in cellular membranes are not yet
well defined, there are no definitive negative controls for
noninteracting proteins. Usually, unrelated membrane pro-
teins are assumed to be noninteracting, without rigorous
tests for the lack of such interactions.
Here, we address all the above issues by providing a
computational description of proximity FRET, and by
identifying several integral membrane proteins that do not
interact and allow for experimental characterization of
proximity FRET. First, we revisit the simulations of Snyder
and Freire, which were carried out for a limited number
of fluorophore concentrations and distances of closest
approach (20). We improve upon their numerical results
by simulating monomeric fluorophores over a wider range
of exclusion radii and acceptor concentrations. Second, we
calculate the theoretical proximity contribution for oligo-
meric arrangements of fluorophores, accounting for their
finite size and geometric arrangement. We demonstrate
that both the distance of closest approach between fluoro-
phores and their oligomeric state affect the magnitude of
the proximity-FRET contribution. Furthermore, the mono-
mer predictions that we generate allow us to identify integral
membrane proteins from the receptor tyrosine kinase (RTK)
family that do not interact in mammalian membranes and
thus can be used as negative controls in FRET experiments
in cellular systems. We measure the FRET signatures of
these proteins, tagged with YFP and mCherry fluorescent
protein, in plasma-membrane-derived vesicles. We accom-
plish this with the help of the quantitative-imaging FRET
(QI-FRET) method (21,22), which yields not only the
FRET efficiency but also the donor and acceptor concentra-
tions. By fitting the model to the experimental data, we
obtain the distance of closest approach between fluorophores
for the different RTK/fluorescent protein pairs studied here.NUMERICAL METHODS
Proximity FRET
When confined to two dimensions, even at relatively low concentrations,
donors and acceptors can randomly approach each other such that theBiophysical Journal 106(6) 1309–1317energy of an excited donor can be transferred to an acceptor. This type of
random proximity FRETwill occur even in the absence of sequence specific
interactions.
As shown by Wolber and Hudson (15), in a static quenching experiment,
the relative quantum yield for a donor surrounded by a random configura-
tion, b, of N acceptor molecules is
qðbÞr ¼
"
1þ
XNb
i¼ 1

R0=Ri
6#1
: (1)
In Eq. 1, Ri is the distance from the ith acceptor molecule to the donor
and R0 is the Fo¨rster Radius, a property of the donor-acceptor FRET pair.
The Fo¨rster radius is the donor-acceptor distance, R0, at which resonance
energy transfer efficiency, E, is decreased to 50% (11). Therefore,
E ¼ R
6
0
R60 þ R6
: (2)
The ensemble average of Eq. 1 over all configurations of acceptor
molecules equals the ratio of the donor quantum yield in the presence
(QDA) and absence (QD) of the acceptor molecule (15):
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The proximity FRET depends only on the acceptor concentration (15),
and thus it can be predicted based on quantum yield calculations for a single
donor surrounded by a random configuration of acceptors. However, certain
cases are more complex (see below), and configurations of multiple donors
may need to be considered. As shown by Snyder and Freire (19), if multiple
excited donors, ND, are available to transfer their energies to a random
configuration of acceptors, the ratio of quantum yields shown in Eq. 3
becomes
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The proximity-FRET transfer efficiency, E, for a given acceptor concen-
tration is then given by Eq. 5:
E ¼ 1 QDA=QD: (5)
Wolber and Hudson developed analytic equations to calculate proximity
FRET as a function of acceptor concentration (15). These equations, how-
ever, are valid for point fluorophores only, and break down when the
excluded volumes of donor and acceptor molecules become relevant, as
in the case of fluorescent proteins with diameters of ~3 nm and Fo¨rster
radius of ~5.4 nm. Snyder and Freire used computer simulations and the
equations above to determine proximity FRET (19) that is valid for mono-
mers of finite size. As discussed below, we improve here upon their numer-
ical result by simulating over a wider range of exclusion radii and a finer
grid of acceptor concentrations. We also calculate, for the first time to
our knowledge, the proximity-FRET contribution as a function of the olig-
omeric state and geometry of the membrane protein complexes.
In our simulations, we specifically model the case of integral membrane
proteins that are labeled with fluorescent proteins at their termini. We
assume that the attachment of the fluorescent proteins is through an
intrinsically disordered linker, and thus the fluorophores adopt random
orientations. Furthermore, the fluorescent proteins are confined to the
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Thus, we can forego simulations of the complicated membrane environ-
ment and focus solely on the generation of random 2-D configurations of
fluorophores with limited distances of closest approach, L. The simulation
is performed in 2-D, and the fluorophores are modeled as circles of a fixed
exclusion radius, r. In the case when donor and acceptor molecules are fluo-
rescent proteins fused to identical membrane proteins, this distance of
closest approach, L, is twice the exclusion radius, 2r, of the 3-D volume
sampled freely by the fluorescent protein.FIGURE 1 Predictions for proximity FRET for monomers, dimers, tri-
mers, and tetramers, as a function of acceptor concentration.Proximity FRET for monomeric membrane
proteins
To simulate proximity FRET for monomeric membrane proteins, a lone
donor molecule is placed in the center of a 2-D, square simulation region
(Fig. S1 in the Supporting Material). For each simulated acceptor concen-
tration, the number of acceptor molecules is calculated and acceptors are
placed one by one into the simulation region until the desired surface den-
sity is reached. For each acceptor molecule to be placed, a random position
is chosen within the simulation region and evaluated against the condition
of no overlap. If no overlap occurs between the newly placed acceptor and
any other previously placed molecule, including the central donor mole-
cule, the position is chosen as acceptable. If not, then a new random posi-
tion is chosen and the position is evaluated again against the condition of no
overlap. This is repeated until all of the acceptor molecules are successfully
placed without overlap within the simulation region. Equation 1 is then used
to calculate the quantum yield of the central donor in the presence of the
random configuration of acceptors. After this is done for a large ensemble
of such configurations, Eqs. 3 and 4 are used to calculate the simulated
proximity FRET as a function of acceptor concentration.
The case of proximity FRET in the case of noninteracting fluorophores
with finite volume has been considered previously by Snyder and Freire,
with the only difference being the method of molecular placement (20).
They used an elegant Monte Carlo approach to generate the various
acceptor configurations, from which curves of QDA/QD were generated
for different values of L/R0 (19). Each curve was fitted to an exponential
function of acceptor concentration per R0
2, [c], and the dependence of
the best-fit parameter on L/R0 was modeled with a third-order polynomial
function. The equations used were
QDA=QD
¼ expðAðL;R0Þ  CÞ; (6)
where
AðL;R0Þ ¼
X3
i¼ 0
ai

L
R0
i
; (7)
and
C ¼ ½c  R20: (8)
With ai determined by fitting A as a function of L/R0, this form of the rela-
tive quantum yield can be used in any nonlinear least-squares fitting algo-
rithm to determine the best-fit value of L for a data set, when R0 is known.
Since the publication of these results, 30 years have passed, during
which computer power has increased immensely. As such, we performed
monomer-only simulations over a much finer mesh of acceptor concentra-
tions and exclusion radii than was possible previously. We found, in agree-
ment with previous work, that the relative quantum yields, as a function of
acceptor concentration, were modeled well as an exponential function of
the form shown in Eq. 6. Employing a finer mesh of simulated exclusion
radii allowed us to confirm that A was indeed a smooth function of the
exclusion radius. The finer mesh of acceptor concentrations used in thesimulations, which determines the value of A in a least-squares sense,
showed that a fifth-order polynomial more accurately models the depen-
dence of A as a function of the fluorophore exclusion radius. The inclusion
of additional terms did not significantly improve the quality of the fit. Thus,
our refined prediction for the relative quantum yield is given by Eq. 6,
where
AðL;R0Þ ¼
X5
i¼ 0
ai

L
R0
i
(9)
and
a0 ¼ 3:638 a1 ¼ 0:354 a2 ¼ 0:214
a3 ¼ 7:007 a4 ¼ 5:642 a5 ¼ 0:919
The proximity-FRET contribution due to random approach of mono-
meric fluorophores was simulated on a 150  150 nm2 2-D plane (see
Fig. S1). Acceptor concentrations ranging from 0 to 0.01 acceptors/nm2
were used in the simulations, and the simulations were run for exclusion
radii ranging from 0 to 4 nm, in 0.02 nm steps. These simulations were
performed for N¼ 40,000 different configurations at each acceptor concen-
tration. The Fo¨rster radius for the YFP-mCherry FRET pair of 5.4 nm was
utilized in the generation of the curves of relative quantum yield. In Fig. 1,
we show the results of a simulation when the distance of closest approach is
2.8 nm, corresponding to an effective exclusion radius of 1.4 nm.Proximity FRET for oligomeric membrane
proteins
The cases of constitutive oligomers confined to two dimensions are more
complex than the monomer case, as the oligomers can have a specific
orientation within the plane of the membrane (see angle f in Fig. S2 B).
The total number of fluorophores is calculated from the acceptor concen-
tration and the donor/acceptor ratios. Next, the number of oligomers is
calculated based on the total concentration. A central oligomer is placed
in the center of the simulation region and assigned a random orientation
angle, f. Random (x,y) positions are assigned for the locations of the cen-
ters of the remaining oligomers, and orientation angles are chosen with a
random number generator. The positions of the fluorophores are calculated
based on the orientation angle and the position of the center of the olig-
omer. The fluorophore positions within each oligomer are compared to
the positions of all the previously placed oligomers to ensure that noBiophysical Journal 106(6) 1309–1317
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overlap occurs, this location is chosen as an acceptable oligomeric position.
Conversely, if overlap has occurred with another molecule, a new position
and orientation angle are chosen until a no-overlap position is identified.
Once all the oligomers have been placed, one of the central oligomeric
fluorophores is randomly selected to be a donor, hereafter called the central
donor. Next, some fluorophores are randomly assigned to be donors, based
on the donor fraction. Once all of the donors have been selected, the re-
maining fluorophores are assigned to be acceptors. Equations 4 and 5 are
then applied to determine the relative quantum yield of the donor for
that specific configuration of fluorophores for all of the acceptor molecules
not assigned to the central oligomer. This yields proximity FRET between
oligomers, as there are no intraoligomeric donor-to-acceptor distances used
in the calculations.
The proximity-FRET contributions due to random approach of dimers,
trimers, and tetramers were simulated on a 150  150 nm2 2-D plane
(Figs. S2–S4). Acceptor concentrations ranging from 0 to 0.01 acceptors/
nm2 were used in the simulation, and the simulations were run for four
donor/acceptor ratios: 0.1, 0.2, 0.3, and 0.4. These simulations were per-
formed for N ¼ 40,000 times at each acceptor concentration and each
donor/acceptor ratio. The Fo¨rster radius for the YFP-mCherry FRET pair
of 5.4 nm was utilized in all simulations. The distance between the fluoro-
phores in the oligomers was fixed at d¼ 50 A˚. This distance corresponds to
an intrinsic FRET efficiency of 0.6 for a dimer labeled with a donor and an
acceptor.Proximity FRET for membrane proteins in
monomer-dimer equilibrium
This case is more complex than the previous cases, as a lone donor placed in
the center of the simulation region can exist either as a monomer or as part
of a dimeric arrangement. For this reason, in this set of simulations we did
not calculate the quantum yield of a single acceptor-quenched donor;
instead, we calculated the quantum yield of all excited donors randomly
placed within a 50  50 nm2 central region centered within the 150 
150 nm2 simulation region (see Fig. S5). Wolber and Hudson (15) used a
similar central-region approach, which offers the advantage of avoiding
edge effects experienced with donor placement near the edge of the simu-
lation region. The FRETefficiency due to proximity is calculated using Eqs.
4 and 5 for all donor molecules within the central region. Thus, FRET is
averaged over donors in both the monomeric and dimeric configurations
in this simulation. If an acceptor molecule is in a dimer with a donor mole-
cule in the central region, that intermolecular distance is not used in Eq. 5,
since this acceptor is not contributing to the proximity FRET, but instead is
engaging in FRET due to sequence-specific dimerization.
During each trial, the predetermined acceptor concentration and donor/
acceptor ratio are used to calculate the total number of molecules, the
number of acceptors, and the number of donors to be placed within the
simulation region. Based on a given dimerization free energy, DG ¼
RT ln(K), whereK is the equilibrium association constant for the two-state
model, the fraction of dimers as a function of total fluorophore concentra-
tion is calculated. Based on the total number of simulated molecules, the
number of molecules to be placed in a dimeric configuration is then
determined, also yielding the number of monomeric fluorophores. In all
trials, the first molecule (monomer or dimer) to be placed is assumed to
be a donor fluorophore and is placed randomly within the region of interest
inside the simulation region. The probability that this molecule is a dimer is
equal to the fraction of dimers designated for that trial. A random number
between 0 and 1 is chosen, and if this number is between 0 and the expected
fraction of dimers, then the first molecule placed is a dimer. Otherwise, the
first molecule placed in the region of interest is a monomer. The purpose of
placing the first molecule within the region of interest, as opposed to
randomly within the entire simulation region is to ensure that at least one
donor molecule is excited and can transfer its energy to an acceptor
configuration.Biophysical Journal 106(6) 1309–1317After placement of the first monomer or dimer, the remaining dimers are
placed randomly within the simulation region and are given a random orien-
tation, ensuring that no spatial overlap takes place between all previously
placed fluorophores. The remaining monomers are then placed randomly
within the simulation region, and again the condition of no overlap between
the newly placed fluorophore and all previously placed fluorophores is
enforced. Once all the monomers and dimers have been placed in the simu-
lation region without overlap for a particular trial, the fluorophores are
randomly assigned to be either donors or acceptors. After completion of
all trials for a given acceptor concentration and donor/acceptor ratio, Eqs.
4 and 5 are used to calculate the theoretical proximity FRET.
Monomeric fluorophores were modeled as circles of radius r ¼ 1.4 nm
and dimeric structures consisted of two circles of radius r ¼ 1.4 nm sepa-
rated by an intramolecular distance d ¼ 5 nm. Acceptor concentrations
were varied from 0 to 0.01 acceptors/nm2, and donor/acceptor ratios of
0.1, 0.2, 0.3, and 0.4 were used in the simulations, with 30,000 trials per
simulated acceptor concentration and donor/acceptor ratio. Predictions
were created for different values of the dimerization free energy, DG.EXPERIMENTAL METHODS
Plasmid constructs
The pRSETB-mCherry plasmid was a gift from Dr. R. Tsien (University of
California, San Diego) and the YFP plasmid was a gift from Dr. M. Beten-
baugh (Johns Hopkins University, Baltimore, MD). The plasmid encoding
human wild-type fibroblast growth factor receptor (FGFR)1/IIIc in the
pRK5 vector was a gift from Dr. M. Mohammadi (New York University,
New York). All of the plasmids used for mammalian expression were
constructed in the pcDNA 3.1(þ) vector (Invitrogen, Carlsbad, CA), and
all primers for FGFR1 were purchased from Invitrogen. The primers
used for ErbB1 (epidermal growth factor receptor) and ErbB2 (human
EGFR 2) cloning were purchased from Integrated DNA Technologies
(Coralville, IA).
Six plasmid constructs (pcDNA-receptor-YFP and pcDNA-receptor-
mCherry) were subcloned for these experiments (see Fig. 3). The two
FGFR1 constructs, pcDNA-FGFR1-YFP and pcDNA-FGFR1-mCherry
encoded the FGFR1 signal peptide, the FGFR1 extracellular domain, the
FGFR1 transmembrane (TM) domain, a 15 amino acid (GGS)5 flexible
linker, and a fluorescent protein (YFP or mCherry) replacing the intracel-
lular domain of the receptor. The two ErbB1 plasmid constructs, pcDNA-
ErbB1-YFP and pcDNA-ErbB1-mCherry, encoded sequences for the signal
peptide of human ErbB1; the extracellular and TM domains of ErbB1, a 15
amino acid (GGS)5 linker, and YFP/mCherry fused at the C-terminus. The
two ErbB2 plasmid constructs, pcDNA-ErbB2-YFP and pcDNA-ErbB2-
mCherry encoded sequences for the signal peptide of human ErbB2,
the extracellular domain and TM domains of ErbB2, and YFP/mCherry
attached to the C-terminus of the TM domain via a 15 amino acid
(GGS)5 linker. The oligonucleotide sequence for the 15 amino acid linker
was identical for all six plasmid constructs.Cell culture and transfection
Chinese hamster ovary (CHO) cells were a kind gift from Dr. M. Beten-
baugh (Johns Hopkins University, Baltimore, MD). Human Embryonic
Kidney (HEK293T) cells were a gift from Dr. D.Wirtz (Johns Hopkins
University). The cells were cultured in Dulbecco’s modified Eagle medium
at 37C with 5% CO2 for 24 h. Transfection was carried out using Fugene
HD transfection reagent (Roche Applied Science, Penzberg, Germany)
according to the manufacturer’s protocol. HEK293T and CHO cells
were cotransfected with 5 mg and 7 mg, respectively, of total DNA.
The DNA encoded either 1), the pcDNA-FGFR1-mCherry and pcDNA-
ErbB1-YFP; 2), the pcDNA-ErbB1-YFP and pcDNA-ErbB1-mCherry;
or 3), the pcDNA-ErbB2-YFP and pcDNA-ErbB2-mCherry.
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vesicles
We used two types of vesiculation buffers. The vesiculation buffer developed
by Scott (23) was used to vesiculate HEK293T cells, and the chloride salt
buffer (24) was used to produce plasma-membrane-derived vesicles from
CHO cells. We have demonstrated that the method of vesicle production
has no statistically significant effects on themeasured FRETefficiencies (25).
HEK293T cells were rinsed once with phosphate-buffered saline (PBS),
pH 7.4, containing 0.75 mM calcium chloride and 0.5 mM magnesium
chloride (CM-PBS), and incubated with 1 mL of vesiculation buffer for
2 h at 37C. The vesiculation buffer consisted of CM-PBS with 25 mM
formaldehyde, 0.5 mM 1,4-dithiotreitol, and a protease inhibitor cocktail
(complete mini EDTA-free tabs, Roche Applied Science). To quench the
formaldehyde after vesiculation, glycine solution in PBS was added to
the vesiculation buffer to a final concentration of 0.125 M. A large number
of vesicles were produced after 1.5 h.
CHO cells were rinsed twice with 30% PBS (pH 7.4), and incubated with
1 mL of chloride salt vesiculation buffer overnight at 37C. The vesicula-
tion buffer consisted of 200 mM NaCl, 5 mM KCl, 0.5 mM MgSO4,
0.75 mM CaCl2, 100 mM bicine, and protease inhibitor cocktail (complete
mini-EDTA-free tabs, Roche Applied Science) adjusted to a pH of 8.5.
After 12 h, the vesicles were transferred into four-well chambered cover-
slips (Nunc Lab-Tek II, Sigma-Aldrich, St. Louis, MO) for imaging.Fluorescence image acquisition
Vesicles were imaged using a Nikon Eclipse confocal laser scanning micro-
scope using a 60water immersion objective. All the images were collected
and stored at a 512  512 resolution. Each vesicle was imaged in three
distinct scans: donor, FRET, and acceptor scans. The donor scan was used
to excite YFP at 488 nm and to collect YFP emission in the 500–530 nm
range. The acceptor scan was used to excite the acceptor at 543 nm and
its emission spectrum was collected in the range >650 nm. For the FRET
scan, YFP was excited and the emission of mCherry was collected in the
565–615 nm range. The imaged vesicles exhibited uniform fluorescence in-
tensities, which allowed us to determine the concentrations of the fluorescent
proteins in the membrane using solutions of purified YFP and mCherry so-
lutions of known concentration. The fluorescent protein solutions were pre-
pared as described previously (21,26). They were imaged in the microscope
using the same settings as above, to allow direct comparison of solution and
vesicle intensities. The FRET efficiencies in each vesicle were determined
using the QI-FRET method, as described in detail previously (22,27,28),
and are shown as a function of acceptor concentration (see Figs. 3 and 4).
The FRET efficiencies for each vesicle were calculated using Eq. 10,
E ¼ 1 ID
ID þ GFðIFRET  bDID  bAIAÞ
: (10)
The intensities ID, IFRET, and IA, are the intensities measured for each
vesicle in the donor, FRET, and acceptor channels, respectively. The param-
eters bD and bA are the donor and acceptor bleed-through coefficients,
obtained by imaging the purified YFP and mCherry solutions, as described
elsewhere (29). The gauge factor, GF, relates the sensitized emission of the
acceptor to the quenching of the donor and is calculated by analyzing ves-
icles loaded with a soluble linked YFP-mCherry construct (21).RESULTS AND DISCUSSION
Predictions for proximity FRET
The proximity contribution to FRET measurements of inter-
actions between membrane proteins in cellular membranes
is quite substantial, and it needs to be accounted for.Although the proximity-FRET contribution has been char-
acterized in lipid bilayers when the donor and the acceptor
are small organic molecules (17,30), there are no assess-
ments of this effect when bulky fluorescent proteins are
used. Steady-state FRET measurements of membrane pro-
tein interactions using fluorescent proteins are often per-
formed (8,9,31,32), and thus the lack of understanding of
proximity FRET in this case is a major obstacle for future
progress. To start bridging this gap, we calculate here the
theoretical proximity contribution while accounting for the
finite size of the fluorophores and the oligomeric state of
the membrane protein complexes. We create the predictions
as a function of acceptor concentration, as this is the rele-
vant parameter (for fixed d, R0, and L) that determines the
magnitude of the proximity FRET (15). We accomplish
this by generating 40,000 different configurations for each
acceptor concentration and applying Eqs. 1–5, accounting
for the interoligomeric donor-to-acceptor distances.
In Fig. 1, we show the simulations for proximity FRET for
monomers (solid line), dimers (dashed line), trimers (dotted
line), and tetramers (dash-dotted line). Predictions are for
monomers with an exclusion radius of 1.4 nm and for dimers,
trimers, and tetramers with an exclusion radius of 1.4 nm and
a distance of 5 nm between fluorophores. We see that in all
cases, the proximity FRET increases when the acceptor
concentration is increased. An important novel result of
this simulation is the fact that the proximity contribution
decreases with the oligomer size. This effect is substantial,
as the contribution for a tetramer is less than half the contri-
bution of the case of monomeric proteins. We can rationalize
these results with the simple notion that the large oligomer
acts as a barrier to the close approach of the acceptors contrib-
uting to proximity FRET. Thus, the distances between these
acceptors and the central donor are larger than in the case of
the monomer, and the proximity-FRET contribution is lower.
Fig. 2 shows the predictions for the case of monomer-
dimer equilibrium. Predictions were generated for different
values of the dimerization free energies. As the free energies
of dimerization vary from 1 kcal/mole to 5 kcal/mole,
the predictions move from a monomer-like proximity to a
dimer-like proximity. Thus, the proximity contribution is a
function of the dimerization propensity.
As discussed inMaterials andMethods, simulations for all
cases shown in Figs. 1 and 2 were carried out for various
donor/acceptor ratios, and herewe show the averaged results.
Our simulations (not shown) reveal a very weak dependence
on this ratio (results werewithin 3%). Thus, like in themono-
mer case (15), the acceptor concentration is the principal
parameter that controls the magnitude of the proximity
FRET in the oligomeric cases.Comparison with experiments: themonomer case
The QI-FRET method, which has been described in detail
previously (22,25,27,28,33), allows rigorous measurementsBiophysical Journal 106(6) 1309–1317
FIGURE 2 Predictions for proximity FRET in the case of monomer-
dimer equilibrium, for different values of the dimerization Gibbs free
energy. (Red line) 100% monomer. (Blue line) 100% dimer.
1314 King et al.of FRET efficiencies as a function of concentration. The
method yields the FRET efficiency and the donor and
acceptor concentrations in each vesicle. In these experi-
ments, mammalian cells are transfected with plasmids
encoding for the membrane proteins of interest, tagged
with fluorescent proteins. After expression, vesicles are
produced, derived from the plasma membranes of the cells,
as discussed in Materials and Methods. We analyze 200–600
individual plasma-membrane-derived vesicles in each
experiment, imaging a thin slice through the equator of
each vesicle. Because the distribution of the membrane
proteins in the vesicles is homogeneous, the fluorescence
of the vesicles can be compared to the fluorescence of solu-
tions of purified fluorescent proteins, allowing the deter-
mination of the donor and acceptor concentrations and the
FRET efficiency. Therefore, this method can be used
for the experimental assessment of proximity FRET in
plasma-membrane-derived vesicles.
Using this technique, we sought to verify the proximity-
FRET calculations presented in this article. A direct verifi-
cation of the predictions can be carried out for monomeric
proteins, as the measured FRET in this case will be equal
to the proximity FRET. In this case, one needs to measure
FRET between two proteins that do not interact, when one
is labeled with a donor and the second with the acceptor.
These proteins can be identical and have the property to
not self-associate into dimers or higher-order oligomers,
or they can be two different noninteracting proteins. A
problem arises, however, in that currently there are no
known adequately characterized monomeric membrane
proteins. Historically, in this field of research, the TM
domain of glycophorin A (GpA) has been used as a control
for a constitutive dimer, whereas a G83I mutant of GpA has
been used as a weakly interacting control (34). However,
this behavior is derived from studies in detergents or pureBiophysical Journal 106(6) 1309–1317lipid bilayers, and GpA dimerization was recently shown
to be very sensitive to lipid composition (35). In fact,
GpA is a rather weak dimer in mammalian membranes,
and the G83I mutation does not cause a strong dimer desta-
bilization in the complex plasma membrane environment
(L. Chen, S. Sarabipour, P. Byrne and K. Hristova, unpub-
lished). Thus, it is not clear what proteins should be selected
as monomeric controls in the experiments.
As we work with RTKs, we searched for RTK constructs
that do not formhomodimers or heterodimers.We engineered
plasmid DNA constructs that encoded for the extracellular
and TM domains of different RTKs, tagged with donor or
acceptors, and we determined the FRET efficiencies with
the QI-FRET method. We sought pairs that 1), give FRET
that is lower than the FRET for other proteinswe haveworked
with; 2), give FRET that is close to the monomer prediction;
and 3), give similar FRET. In three cases—1), truncated
ErbB1 labeled with either YFP or mCherry; 2), truncated
ErbB2 labeled with either YFP or mCherry; and 3), trun-
cated ErbB1 labeled with YFP and FGFR1 labeled
with mCherry—we observed FRET that satisfied these
requirements. In all three cases, the intracellular domains of
these receptors were removed, and substituted with either
YFP or mCherry, connected via a flexible linker to the TM
domain. Protein constructs are shown in Fig. 3 A, and the
measured FRETefficiency for the three experiments is shown
in Fig. 3 B. All three cases display overlapping measured
FRET efficiencies as a function of acceptor concentration.
Furthermore, FRET is lower when compared to other inter-
acting RTK proteins that we have studied in the past with
quantitative FRET techniques (25,28,33). Thus, themeasured
FRET efficiencies strongly suggest that the truncated ErbB1
andErbB2 constructs do not homodimerize, and that the trun-
cated ErbB1 and FGFR1 constructs do not heterodimerize.
Next, we fitted each individual data set while optimizing
for the distance of closest approach between fluorophores,
L, using Eqs. 6, 8, and 9. The data and the fits are shown
in Fig. 4. The best-fit values of L are shown in Table 1, along
with the average. The minimum distance of closest
approach should depend on 1), the size of the fluorescent
proteins, and 2), the size and shape of the RTKs to which
the fluorophore is linked. The optimal values in Table 1
are ~3 nm, comparable to the size of the fluorescent pro-
teins. Thus, it appears that the extracellular glycosylated
domains of the RTKs do not significantly affect the
measured distance of closest approach, L, with the possible
exception of ErbB2 (see Table 1).
In Table 1, we show the fit when our model, given by Eqs.
6, 8, and 9, is used, along with the fit produced by the model
of Snyder and Freire, given by Eqs. 6–8. We see that the fit
results are very similar and within experimental error, sug-
gesting that both models can be used in future work.
In this study, we employed ErbB proteins comprising only
the extracellular and transembrane domain, ErbB1-ECTM
and ErbB2-ECTM, and excluded the intracellular domain.
FIGURE 3 (A) RTK constructs, identified here as the non-interacting
controls. (B) Measured FRET efficiencies for i), truncated ErbB1 labeled
with either YFP or mCherry in CHO derived vesicles, ii), truncated
ErbB2 labeled with either YFP and mCherry in HEK 293T derived vesicles,
and iii), truncated ErbB1 labeled with YFP and truncated FGFR1 labeled
with mCherry in CHO derived vesicles. All the measured FRETefficiencies
fall close to the prediction for monomers. (Solid line) our prediction for L¼
2.8 nm. (Dashed line) prediction of Snyder and Freire (19) for L ¼ 2.8 nm.
TABLE 1 Distances of close approach, L, that yield the best fit
of the model to the experimental data
Data set L (nm)a L (nm)b
ErbB1 15aa 3.0 5 0.4 2.85 0.4
ErbB2 15aa 3.8 5 0.4 3.85 0.2
ErbB1-FGFR1 2.6 5 0.4 2.25 0.4
Average 3.2 5 0.6 3.05 0.6
Fit to all data 3.0 5 0.2 2.85 0.2
aOur model, given by Eqs. 6, 8, and 9.
bModel of Snyder and Freire (19), given by Eqs. 6–8.
FIGURE 4 Fits of the model for monomer proximity FRET to the
measured FRET efficiencies, yielding the optimal distances of closest
approach, L, shown in Table 1. (A) truncated ErbB1 labeled with either
YFP or mCherry in CHO derived vesicles, (B) truncated ErbB2 labeled
with either YFP and mCherry in HEK 293T derived vesicles, and (C) trun-
cated ErbB1 labeled with YFP and FGFR1 labeled with mCherry in CHO
derived vesicles.
FRET Signatures of Noninteracting Proteins in Membranes 1315Full-length ErbB1 and ErbB2 have been reported to form
clusters and preformed homodimers in the absence of ligand
(36–42).However, dimerization is believed to bemediated by
the intracellular domain, which is excluded here (43,44). This
is consistent with the observations that the purified extracel-
lular regions of ErbB1 and ErbB2 do not form dimers at high
concentration in solution or in x-ray crystal structures
(45–48). The ErbB1 extracellular domain takes on a tethered
conformation in the absence of ligand and functions in an
autoinhibitory manner. For the case of ErbB2, the extracel-
lular domain adopts an extended conformation that likely
inhibits homodimerization (49). Although one study (50)
reports on reversible dimerization of ErbB1 lacking the intra-
cellular domain in CHO cells, the majority of the publishedstructural, biochemical, and functional studies suggest that
ErbB receptors that lack intracellular domains are mono-
meric in the absence of ligand, consistent with our results.CONCLUSION
Here, we present predictions for proximity FRET, for
the cases of membrane monomers, dimers, trimers, andBiophysical Journal 106(6) 1309–1317
1316 King et al.tetramers, and we verify this approach by measuring the
proximity FRET for monomeric membrane proteins in
plasma-membrane-derived vesicles. The predictions that
we present here can be used to correct the measured
FRET efficiencies when fluorescent proteins are used in
steady-state FRET experiments, such that the efficiencies
do not contain contributions due to nonspecific interactions.
The computational tools described in this article advance the
FRET-based methodologies used to study interactions
between membrane proteins. As membrane protein inter-
actions underlie many important cellular processes, these
tools should have a broad utility in membrane protein
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